Infectious Disorders - Drug Targets

(Formerly Current Drug Targets - Infectious Disorders)

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Volume 22 , Issue 8 , 2022

This journal supports open access

Back Journal Home
Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

0 Disease(s)

Aims & Scope

Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews and research articles written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development. All aspects related to viral or bacterial diseases including HIV, AIDS and other sexually transmitted diseases (STDs) are also included in the scope of the journal.

Abstracted/Indexed in


BIOBASE, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE/Excerpta Medica, ERA 2018, Genamics JournalSeek, Google Scholar, Index Copernicus, J-Gate, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed/Index Medicus, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM, Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.

Journal History

Current Drug Targets - Infectious Disorders was launched in 2001 and later renamed in 2006 as Infectious Disorders - Drug Targets.

Special Offers

Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.


30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published. Multiple issue copies at discounted rates.


Abstracted/Indexed in
COPE COMPLIANT
New eBook
Frontiers in Clinical Drug Research-Anti Infectives

You can view the contents of this eBook [here]
Endorsement(s)

"The rewards of genomics research translated into novel drug discovery using both traditional and innovative approaches will be captured in reviews of interest both to academic and applied infectious disease researches."

John Mekalanos
Harvard Medical School, USA

Authors' Comments

It is a great pleasure for me working with Bentham Science Publication. Bentham Science Publication “Infectious Disorders – Drug Targets” is one of the best publishers in many fields such as medicinal chemistry , pharmacology…etc, that always aim to develop the pharmaceutical industries.

Hourieh Alkadi
(Faculty of Pharmacy, Arab International University, Syrian Arab Republic.)

© 2022 Bentham Science Publishers | Privacy Policy